A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults
- 23 November 2009
- Vol. 27 (50) , 7080-7086
- https://doi.org/10.1016/j.vaccine.2009.09.060
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Towards an understanding of the adjuvant action of aluminiumNature Reviews Immunology, 2009
- Vaccination in Humans Generates Broad T Cell Cytokine ResponsesThe Journal of Immunology, 2004
- Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowNature Medicine, 2004
- Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2Journal of Virology, 2003
- Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte EpitopesJournal of Virology, 2001
- Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV‐1Mngp120, HIV‐1SF2Recombinant gp120, or Both Vaccines in Seronegative AdultsThe Journal of Infectious Diseases, 1998
- A Randomized, Placebo-Controlled Study of the Immunogenicity of Human Immunodeficiency Virus (HIV) rgp160 Vaccine in HIV-Infected Subjects with >=400/mm3 CD4 T Lymphocytes (AIDS Clinical Trials Group Protocol 137)The Journal of Infectious Diseases, 1996
- The role of lymphoid organs in the immunopathogenesis of HIV infection.1993
- Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.Proceedings of the National Academy of Sciences, 1992
- A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991